Funny Pharm: You Write the Caption & Win: May 2013

"Funny Pharm," features drawings by award-winning cartoonist Jerry King. Submit your caption and win

Funny Pharm: You Write the Caption

Funny Pharm

Pharmaceutical Manufacturing presents "Funny Pharm," featuring drawings by award-winning cartoonist Jerry King.

The winning cartoon caption will be featured on the PharmaManufacturing.com website and in the PharmaManufacturing.com eNewsletter. The winner will receive a coffee mug with the cartoon and winning caption printed on it.

Please submit your caption to cmallari@putman.net. Thank you for your contributions!


Winner:

"It’s a good thing for me that Clinical Trials went Intergalactical!" -Sheldon Krocker

Contending submissions:

"Now is the time to buy low." -Jacob Raszka

"When my neck kept growing, I thought I was getting placebos. But then I grew a tail. Can placebos have a side effect?” -Mark Lad

“I TOLD you that I guessed I was in the placebo arm of the trial!” -Tony Stuckwisch

"I watched so many Christopher Lee movies that I developed Cushing's syndrome." and "Looks like we're running low. Open the peanut jars, please, Hal." and "More testing? The multiple ascending dose alone has driven me MAD." and "I'm studying biology now. Next semester I'll be taking ATX-101." and "How come you eat all the peanuts, and I gain all the weight?" -Bill Russo

"We aren’t relevant until Phase IV, 'A New Hope.'" -Tara Bronson

"Common side effects are red eyes, dizziness and shortness of breath." -Jan Zinser

“Hey Jabba, what are you waiting for? Take it as the first step to fulfilling your dream of wearing Darth Vader’s helmet!” -Samuel Tan

"Side effects include clammy skin, red watery eyes, agitation, and backache." - Ben Locwin

“May the farce be with you…” - Doug Williams

"We should have read the fine print about the side effects." - Hugo Lagomasino

 

 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments